Panagioti Bozori Eirini

Panagioti Bozori Eirini Internist

Education & Academic Qualifications

  • Certified Physician of Internal Medicine 2000

Post –Grand, Continuing Education:

  • Monitoring continuing medical education seminars “Evaggelismos” Hospital 1995-2000
  • Clinical education in ICU,”Evaggelismos” Hospital, Director Prof.H.Roussos.
  • Annual further training courses on Diabetes mellitus 1998-2014
  • Monitoring postgraduate seminars in infections diseases from 2006 until 2015
  • Monitoring seminars “Days of internal diseases ” per year from 2000

 

Fellowship in Societies, Membership in Journal Editorial Committees

  • Member of Athens Medical Association

  • Member of Greek Infections Diseases Association 

  • Member of Greek Hematologic Association

  • Member of Greek Alzheimer Disease and Related disorders

 

Work Experience

  • Resident of Internal medicine 1st internal medicine clinic, General Hospital “Laiko Nosokomeio “, Athens 1992-1993.

  • License to practice medicine , Perfecture of Ioannina.

  • Resident of internal medicine –Oncology clinic- Director Prof. K. Alexopulos 04/1995-04/1996.

  • Resident of internal medicine ,5-th Internal Medicine Clinic, General Hospital “ O Evaggelismos”, Director Prof. G. Chalevelakis 04/1996-10/2000.

  • Free medical profession – 3/2000. Internist, clinical Fellow 2nd, internal medicine clinic, Hygeia Hospital Director

  • C. Lyberatos 11/2000 -07/2004.

  • Internist, clinical fellow (grade B) and (grade A) Vrakidou team-Internal Sector- Hygeia Hospital: 2003-2011.

  • Consultant of Hygeia Hospital 09/2011- Present.

 

Clinical & Research Interest

Clinical Interest:

  • Infections Diseases.

  • Diabetes Mellitus.

  • Hematological Diseases.

Research Interest:

  • Hematology.

  • Oncology.

  • Infections diseases.

 

Recent Publications

  • Eur J Orthop. Surg.Traumatol.Heparin-Induced Thrombocytopenia: A rare manifestation in case of uncemented total hip replacement and review of the literature

  • The karyotypic composition of myelodysplastic syndrome exhibits greater Homogeneity in the WHO Classification system – compared to FAB

  • V617 F JAK-2 MUTATION: Reliable indicator clonality and differential diagnosis in years Myeloproliferative

  • Diseases

  • The CA125 INDEX Term in patients with Hodgkin and non Hodgkin Diseases

 

Ενώνουμε τις δυνάμεις μας για μια νέα εποχή υγείας.

Το site του ΜΗΤΕΡΑ βρίσκεται σε φάση ανανέωσης και μέσα στους επόμενους μήνες θα ενσωματωθεί στο site του ΥΓΕΙΑ (www.hygeia.gr), ώστε να σας προσφέρουμε μια πιο ολοκληρωμένη και ενιαία online εμπειρία.

Σας ευχαριστούμε για την κατανόηση.
Μείνετε συνδεδεμένοι — οι αλλαγές έρχονται σύντομα.